Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

D4A and response to abiraterone in castration- resistant prostate cancer (CRPC)

Editor By No Comments1 Min Read

Dr. Petros Grivas, MD of Cleveland Clinic discusses The association of D4, 3-keto-abi (D4A) and response to abiraterone in castration-resistant prostate cancer (CRPC) from ASCO GU 2016.

Share.

Related Posts